The tumor microenvironment is the complex ecosystem that surrounds and sustains cancer cells. It includes blood vessels, immune cells, fibroblasts, signaling molecules and the extracellular matrix. Rather than being a passive backdrop, this environment actively supports tumor growth, shapes cancer evolution and influences how tumors respond to therapy.

Cancer cells remodel their surroundings by secreting growth factors, cytokines and enzymes that degrade and reorganize the matrix. This remodeling creates space for expansion and generates biochemical cues that promote proliferation, invasion and metastasis. Tumor blood vessels are often abnormal and leaky, leading to regions of low oxygen and acidity. These harsh conditions select for more aggressive, therapy resistant cancer cell clones and alter the behavior of stromal and immune cells.

Immune cells in the microenvironment can both attack and protect tumors. While some T cells and natural killer cells mount antitumor responses, other populations, such as regulatory T cells and myeloid derived suppressor cells, dampen immunity and help tumors evade recognition. Cancer associated fibroblasts further contribute by secreting factors that stimulate cancer cell survival, migration and drug resistance.

Understanding the tumor microenvironment has transformed cancer research and treatment strategies. It explains why genetically similar tumors can behave differently and why some therapies fail despite targeting key cancer cell pathways. Current approaches aim to reprogram or disrupt this environment, for example by normalizing blood vessels, modulating immune cell activity or targeting fibroblasts and matrix components. By viewing cancer as a disease of both cells and their niche, researchers are developing more precise and durable therapeutic interventions.